Skip to main content
Deciphera
Deciphera Medical Affairs
  • Our Company
    • Who We Are
    • Leadership
  • Focus Areas
    • Overview
    • Oncology
    • Immunology & Inflammation
    • Neurology
  • Pipeline
    • Ongoing Clinical Trials
    • Presentations & Publications
  • Patients & Care Partners
    • Expanded Access
  • Healthcare Professionals
  • Our Medicines
  • Join Us
    • Our Culture
    • Open Positions
  • News
  • Ono Pharma

News

News

Archive
June 20, 2018

Deciphera Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Archive
June 13, 2018

Deciphera Pharmaceuticals, Inc. to Present at the JMP Securities 2018 Life Sciences Conference

Archive
June 11, 2018

Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock

Archive
June 6, 2018

Deciphera Pharmaceuticals Announces Pricing of Public Offering

Archive
June 4, 2018

Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock

Archive
June 2, 2018

Deciphera Pharmaceuticals Reports Updated Interim Phase 1 Clinical Study Results with DCC-2618 at The 2018 American Society of Clinical Oncology Annual Meeting (ASCO) and Provides Additional Clinical and Regulatory Updates on DCC-2618

Archive
May 29, 2018

Deciphera Pharmaceuticals Appoints Stephen B. Ruddy, Ph.D. as Chief Technical Officer

Archive
May 21, 2018

Deciphera Pharmaceuticals Expands Board with the Election of Mr. Steven L. Hoerter as a Director

Archive
May 14, 2018

Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

Archive
May 8, 2018

Deciphera Pharmaceuticals, Inc. Announces First Quarter 2018 Financial Results

Pagination

  • First page ‹‹ First
  • Previous page ‹ Prev
  • …
  • Page 19
  • Current page 20
  • Page 21
  • …
  • Next page Next ›
  • Last page Last ››

© 2026 Deciphera Pharmaceuticals, LLC. Deciphera Pharmaceuticals, LLC, DECIPHERA, and the Deciphera logo are registered trademarks of Deciphera Pharmaceuticals.

  • Privacy Policy
  • Contact Us
  • Terms of Use
linkedin twitter
DCPH-M01057 v1 10/26
Back to top